Sign In
Free Newsletter
In August 2022, Eisai Inc. cut the ribbon on a 15-story, 332,800-square-foot space in Nutley that serves as the hub for the company, which is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd. - PROVIDED BY EISAI INC.
In August 2022, Eisai Inc. cut the ribbon on a 15-story, 332,800-square-foot space in Nutley that serves as the hub for the company, which is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd. - PROVIDED BY EISAI INC.
Eisai | The Power List
2024 NJBIZ New Jersey Businesses Power List
NJBIZ STAFF//December 9, 2024//
A leader in Alzheimer’s research for decades, Eisai is among one of the few pharmaceutical companies with a drug to treat the root causes of a condition that affects more than 55 million people worldwide.
Recently named as one of Time magazine’s most influential companies and one of Newsweek’s most trustworthy companies in the world, the Japanese pharmaceutical giant has long had a presence in New Jersey.
As a research-based firm dedicated to improving the lives of people affected by cancer, Alzheimer’s disease and other neurodegenerative conditions, Eisai’s business is split into two groups – oncology and neurology.
In 2022, the company relocated its U.S. headquarters from Woodcliff Lake to Nutley where it has a 332,800-square-foot space on the ON3 Campus for commercial and clinical development operations.
